Cytokinetics, Inc. (CYTK) Reports In-Line Q2 Loss of 13c/Share
Tweet
Share
E-mailGet Alerts CYTK Hot Sheet
Price: $74.84 -1.06%
Financial Fact:
Research and development: 19.34M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Research and development: 19.34M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Cytokinetics, Inc. (NASDAQ: CYTK) reported Q2 EPS of ($0.13), in-line with the analyst estimate of ($0.13).
For earnings history and earnings-related data on Cytokinetics, Inc. (CYTK) click here.
For earnings history and earnings-related data on Cytokinetics, Inc. (CYTK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies sees a buying opportunity in this S&P 500 sector
- Azitra, Inc. (AZTR) Tops Q2 EPS by 54c
- Cytokinetics (CYTK) PT Raised to $103 at JPMorgan
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
